Tadala Black
Tadala Black Price range: $ 73,00 through $ 580,00
Back to products
Tadalista
Tadalista Price range: $ 42,00 through $ 414,00

Tadalis SX

Price range: $ 56,00 through $ 219,00

Tadalis SX is a highly effective medication specifically formulated to treat erectile dysfunction and enhance male sexual performance. Utilizing the active ingredient Tadalafil, this treatment works by increasing blood flow to the pelvic region to support a firm and lasting erection. Many users prefer this option because it offers an extended window of efficacy, often remaining active in the system for up to 36 hours. This long-lasting formula allows for greater spontaneity and provides the confidence needed for a satisfying intimate experience. Each tablet is manufactured to high quality standards, ensuring a reliable solution for men looking to improve their sexual health and overall well-being.

Active substance: Tadalafil
SKU: Tadalis SX Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Tadalis SX contains tadalafil, a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). In the United States, tadalafil formulations are prescription-only medications dispensed in accordance with applicable federal and state regulations under appropriate medical supervision.

This therapeutic agent is primarily utilized to restore erectile function by enhancing arterial blood flow to vascular smooth muscle during sexual stimulation. Proper clinical assessment by a healthcare provider is essential prior to initiation to screen for underlying cardiovascular risks and potential drug-drug interactions.

Parameter Specification
Active ingredient Tadalafil
Therapeutic class Phosphodiesterase Type 5 (PDE5) Inhibitor
Route of administration Oral
Dosage form Oral tablet
Primary purpose Treatment of erectile dysfunction
Prescription status Prescription required (Rx only)

Main uses

Tadalafil, the active pharmaceutical ingredient in Tadalis SX, is indicated for the management of erectile dysfunction (ED) in adult males. In clinical practice, erectile dysfunction is defined as the persistent inability to attain or maintain a penile erection sufficient for satisfactory sexual performance. The drug requires intact neuronal and vascular pathways, as well as sexual stimulation, to demonstrate therapeutic efficacy.

While certain regulatory approvals for tadalafil extend to the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) and pulmonary arterial hypertension (PAH), those conditions require specific dosing schedules and clinical oversight. Any application outside of established regulatory labeling is considered off-label and requires explicit medical authorization.

How the drug works

During physiological sexual arousal, nitric oxide is released from local nerve endings and endothelial cells into the corpus cavernosum of the penis. Nitric oxide stimulates the enzyme guanylate cyclase, resulting in elevated intracellular levels of cyclic guanosine monophosphate (cGMP). Increased cGMP promotes smooth muscle relaxation in the penile arteries and erectile tissue, facilitating blood inflow and organ engorgement.

Tadalafil acts as a competitive inhibitor of PDE5, the enzyme responsible for the degradation of cGMP in the vascular smooth muscle. By inhibiting PDE5 activity, tadalafil preserves intracellular cGMP levels, thereby amplifying the physiological erectile response to endogenous nitric oxide release. It does not exert a direct relaxant effect on isolated human corpus cavernosum tissue in the absence of sexual stimulation.

How it’s absorbed and eliminated

Following oral administration, tadalafil is rapidly absorbed into the systemic circulation. Maximum observed plasma concentrations (Cmax) are attained between 30 minutes and 6 hours post-dose, with a median peak time (Tmax) of approximately 2 hours. The rate and extent of systemic absorption are not meaningfully affected by food co-administration. Tadalafil exhibits wide tissue distribution and is approximately 94% bound to plasma proteins in healthy individuals.

The compound is extensively metabolized by hepatic enzymes, primarily via the cytochrome P450 3A4 (CYP3A4) pathway. Its major circulating metabolite is a catechol glucuronide, which displays negligible affinity for PDE5. Tadalafil has a mean terminal elimination half-life of approximately 17.5 hours in healthy adult males. Excretion occurs predominantly as inactive metabolites, with approximately 61% eliminated in feces and 36% excreted in urine.

Dosing schedule

Dosing regimens for tadalafil must be individualized based on clinical response, tolerability, and underlying patient comorbidities. For on-demand administration prior to anticipated sexual activity, the typical initial dose is 10 mg taken orally. Depending on individual efficacy and side effect profile, the dose may be increased to a maximum of 20 mg or decreased to 5 mg. The medication is recommended to be taken at least 30 minutes before activity.

Alternatively, a daily low-dose strategy (2.5 mg or 5 mg taken once daily at approximately the same time) may be prescribed for patients anticipating frequent sexual activity. Tablets should be swallowed whole with fluid. Renal impairment requires dosage adjustment: for patients with moderate renal insufficiency (creatinine clearance 30 to 50 mL/min), a lower starting dose is indicated, whereas severe renal impairment (creatinine clearance under 30 mL/min) limits maximum recommended exposure.

Adverse reactions

Data from controlled clinical trials show that most adverse events associated with tadalafil are mild or moderate in intensity and transient in duration. The most commonly reported side effects include headache, dyspepsia, back pain, myalgia, nasal congestion, facial flushing, and pain in the extremities. Back pain and myalgia typically develop 12 to 24 hours after administration and generally resolve within 48 hours without medical treatment.

Less common adverse reactions include visual disturbances (such as changes in color vision or conjunctival hyperemia), dizziness, and gastroesophageal reflux. Post-marketing surveillance has identified rare instances of severe hypersensitivity reactions, including Stevens-Johnson syndrome and exfoliative dermatitis. Patients who experience persistent or severe adverse effects should notify their healthcare provider.

Important precautions

The administration of tadalafil to patients who are using any form of organic nitrate (such as nitroglycerin, isosorbide mononitrate, or isosorbide dinitrate) or soluble guanylate cyclase stimulators (such as riociguat) is strictly contraindicated. Co-administration can induce severe, sudden drops in systemic blood pressure, leading to syncope, myocardial ischemia, or cerebrovascular events. Cardiovascular risk assessment must precede therapy initiation in men for whom sexual activity is clinically inadvisable.

Precaution is required in patients with anatomical penile deformities (e.g., Peyronie’s disease) or conditions that predispose to priapism (e.g., sickle cell anemia, multiple myeloma, leukemia). Tadalafil is not indicated for pediatric patients or female populations unless specifically evaluated under separate, approved regulatory indications.

Compatibility with other medicines

Tadalafil is clearance-dependent on hepatic CYP3A4 metabolism. Concurrent use with strong CYP3A4 inhibitors (such as ketoconazole, itraconazole, ritonavir, or erythromycin) significantly increases tadalafil AUC and Cmax, requiring conservative dose reductions (often limited to a maximum of 10 mg every 72 hours). Conversely, co-administration with strong CYP3A4 inducers (such as rifampin, carbamazepine, or phenytoin) reduces plasma tadalafil exposure, which may diminish clinical efficacy.

When administered alongside alpha-blockers (e.g., tamsulosin, doxazosin) or other antihypertensive agents, additive blood pressure-lowering effects may occur. Patients should be clinically stable on alpha-blocker therapy prior to initiating tadalafil, and therapy should be started at the lowest recommended dose to minimize the risk of symptomatic orthostatic hypotension.

What to avoid while taking it

Although food does not significantly alter tadalafil pharmacokinetics, heavy consumption of high-fat meals prior to ingestion may slightly delay the time to maximum plasma concentration. Alcohol consumption warrants caution during treatment. Because both alcohol and tadalafil act as mild peripheral vasodilators, combining substantial amounts of alcohol (e.g., 5 units or more) with tadalafil can exacerbate orthostatic signs and symptoms, including dizziness, tachycardia, and standing hypotension.

Additionally, grapefruit juice contains compounds that inhibit intestinal CYP3A4 enzymes. Consuming significant quantities of grapefruit juice while taking tadalafil may elevate systemic drug concentrations, increasing the likelihood of adverse side effects.

Red flags

Patients taking tadalafil must seek immediate emergency medical care if any of the following serious conditions occur:

  • An erection lasting longer than 4 hours (priapism), which can lead to permanent erectile tissue damage if not treated promptly.
  • Sudden decrease or total loss of vision in one or both eyes, which may indicate non-arteritic anterior ischemic optic neuropathy (NAION).
  • Sudden hearing impairment or sudden loss of hearing, sometimes accompanied by tinnitus and dizziness.
  • Chest pain, shortness of breath, severe dizziness, or irregular cardiac rhythm during or after sexual activity.
  • Signs of a severe allergic response, including facial swelling, urticaria, or severe difficulty breathing.

If you skip a dose

For patients prescribed a daily regimen (2.5 mg or 5 mg once daily), a missed dose should be taken as soon as it is remembered on that day. If it is nearly time for the next scheduled dose, the missed dose should be skipped, and the regular schedule resumed. Patients should not double the dose or take extra medication to compensate for a missed tablet. For patients utilizing an on-demand dosing strategy prior to sexual activity, missed dose protocols do not apply.

Storage and expiration

Tadalis SX tablets should be stored at controlled room temperature, ideally between 68°F and 77°F (20°C to 25°C), with brief excursions permitted between 59°F and 86°F (15°C to 30°C). Maintain the medication in its original blister packaging to protect it from excessive moisture and light exposure. Keep out of reach of children and pets. Do not use tablets beyond the expiration date stamped on the package. Expired or unused drugs should be disposed of via local medicine take-back programs or state-approved disposal guidelines.

Common questions

How does tadalafil differ in duration from short-acting PDE5 inhibitors?

Tadalafil exhibits a prolonged terminal elimination half-life of approximately 17.5 hours. This extended pharmacokinetic profile allows therapeutic activity to persist for up to 36 hours post-dose in many patients, compared to 4 to 6 hours for shorter-acting agents in the same class.

Is driving or operating machinery safe while using this medication?

Clinical studies indicate that dizziness and transient visual changes can occur in some individuals. Patients should assess their personal reaction to tadalafil before driving, operating heavy machinery, or engaging in tasks requiring sharp mental alertness.

Can tadalafil tablets be taken daily regardless of sexual activity?

Daily administration is appropriate only when specifically prescribed by a physician as a once-daily low-dose regimen (2.5 mg or 5 mg). On-demand doses of 10 mg or 20 mg are not intended for continuous daily use due to cumulative drug exposure.

What immediate step should be taken if an erection persists too long?

An erection lasting beyond 4 hours constitutes a medical emergency known as priapism. The patient should seek immediate emergency medical care to evaluate and relieve the condition, preventing permanent ischemia to the corpus cavernosum.

Does food intake affect the onset time of this drug?

Food does not significantly alter the overall extent of absorption (AUC) or maximum concentration (Cmax) of tadalafil. While high-fat meals do not alter bioavailability, individual variation in digestive speed may cause minor differences in onset.

In accordance with FDA requirements.

This text is for informational purposes only and does not constitute individual medical advice.

Additional information
Dosage

20mg

Package

30 pills

,

60 pills

,

90 pills

,

120 pills

,

180 pills

Ενεργός Ουσία